Equities researchers at B. Riley lowered their Q1 2025 earnings per share (EPS) estimates for shares of Abacus Life in a ...

Equities research analysts at B. Riley dropped their Q2 2025 earnings per share (EPS) estimates for Trevi Therapeutics in a ...

B. Riley sees mixed Q4 results but gains aftermarket interest. Despite mild improvements, my long-term view on RILY stock is negative. Read an analysis here.

Fintel reports that on March 19, 2025, B. Riley Securities downgraded their outlook for Quanta Services (NYSE:PWR) from Buy ...

B. Riley Financial, Inc.’s RILY share price has dipped by 10.10%, which has investors questioning if this is right time to buy.

B. Riley Securities, the investment banking group, has merged with Cascadia Investments Inc., a shell entity. As a result, ...

B. Riley analyst Nick Giles initiated coverage of United States Antimony (UAMY) with a Buy rating and $3 price target U.S. Antimony could more ...

B. Riley Financial Inc. missed the deadline for filing its annual report for a third year in a row, delaying its to return to a normal schedule as the firm deals with the aftermath of soured ...

B. Riley lowered the firm’s price target on Opal Fuels (OPAL) to $5 from $6 and keeps a Buy rating on the shares. Opal Fuels reported Q4 EBITDA ...

Shares of B. Riley Financial were recently down 2.7%, to $4.34. The stock has fallen about 6% this year and 78% over the past 52 weeks.

Miami's decision to trade Butler ended a months-long saga of disgruntlement from the six-time All-Star. There were signs ...